Calcium-permeable AMPA receptors and silent synapses in cocaine-conditioned place preference. 2017

Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.

Exposure to cocaine generates silent synapses in the nucleus accumbens (NAc), whose eventual unsilencing/maturation by recruitment of calcium-permeable AMPA-type glutamate receptors (CP-AMPARs) after drug withdrawal results in profound remodeling of NAc neuro-circuits. Silent synapse-based NAc remodeling was shown to be critical for several drug-induced behaviors, but its role in acquisition and retention of the association between drug rewarding effects and drug-associated contexts has remained unclear. Here, we find that the postsynaptic proteins PSD-93, PSD-95, and SAP102 differentially regulate excitatory synapse properties in the NAc. Mice deficient for either of these scaffold proteins exhibit distinct maturation patterns of silent synapses and thus provided instructive animal models to examine the role of NAc silent synapse maturation in cocaine-conditioned place preference (CPP). Wild-type and knockout mice alike all acquired cocaine-CPP and exhibited increased levels of silent synapses after drug-context conditioning. However, the mice differed in CPP retention and CP-AMPAR incorporation. Collectively, our results indicate that CP-AMPAR-mediated maturation of silent synapses in the NAc is a signature of drug-context association, but this maturation is not required for establishing or retaining cocaine-CPP.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D000076122 Disks Large Homolog 4 Protein A neuronal protein consisting of three PDZ DOMAINS, an SH3 DOMAIN, and a C-terminal guanylate kinase-like region (see MAGUK PROTEINS). It localizes to the POST-SYNAPTIC DENSITY and associates with the cytoplasmic tail of NMDA RECEPTORS and SHAKER POTASSIUM CHANNELS, playing a critical role in NMDA receptor-mediated SYNAPTIC PLASTICITY. Discs Large Homolog 4 Protein,PSD-95 Protein,PSD95 Protein,Postsynaptic Density Protein 95,SAP-90 Protein,SAP90 Protein,Synapse-Associated Protein 90,PSD 95 Protein,SAP 90 Protein,Synapse Associated Protein 90
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse
D017470 Receptors, Glutamate Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases. Excitatory Amino Acid Receptors,Glutamate Receptors,Receptors, Excitatory Amino Acid,Excitatory Amino Acid Receptor,Glutamate Receptor,Receptor, Glutamate
D051528 Guanylate Kinases Catalyzes the ATP-dependent PHOSPHORYLATION of GMP to generate GDP and ADP. Guanylate Kinase,ATP-(d)GMP Phosphotransferase,Erythrocyte protein p55,GMP Kinase,Guanosine Monophosphate Kinase,Guanylate Kinase 1,MAGUK Proteins,Membrane-Associated Guanylate Kinase,Membrane-Associated Guanylate Kinases,Guanylate Kinase, Membrane-Associated,Guanylate Kinases, Membrane-Associated,Kinase 1, Guanylate,Kinase, GMP,Kinase, Guanosine Monophosphate,Kinase, Guanylate,Kinase, Membrane-Associated Guanylate,Kinases, Guanylate,Kinases, Membrane-Associated Guanylate,Membrane Associated Guanylate Kinase,Membrane Associated Guanylate Kinases,Monophosphate Kinase, Guanosine,Proteins, MAGUK,p55, Erythrocyte protein,protein p55, Erythrocyte

Related Publications

Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
February 2021, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
January 1994, Life sciences,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
April 2011, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
July 2001, Brain research,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
January 2011, Frontiers in molecular neuroscience,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
April 2010, Behavioral neuroscience,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
July 2015, Psychopharmacology,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
February 1992, Arukoru kenkyu to yakubutsu izon = Japanese journal of alcohol studies & drug dependence,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
April 1992, Japanese journal of pharmacology,
Avani Shukla, and Anna Beroun, and Myrto Panopoulou, and Peter A Neumann, and Seth Gn Grant, and M Foster Olive, and Yan Dong, and Oliver M Schlüter
September 2006, Neuroreport,
Copied contents to your clipboard!